4.0 Article

Clinical and neuropathologic findings in a woman with the FMR1 premutation and multiple sclerosis

Journal

ARCHIVES OF NEUROLOGY
Volume 65, Issue 8, Pages 1114-1116

Publisher

AMER MEDICAL ASSOC
DOI: 10.1001/archneur.65.8.1114

Keywords

-

Funding

  1. NCRR NIH HHS [UL1 RR024922, RR024922] Funding Source: Medline
  2. NIA NIH HHS [RL1 AG032115, AG032115, RL1 AG032119, AG032119, RL1 AG032115-02] Funding Source: Medline
  3. NICHD NIH HHS [HD02274, P30 HD002274, R01 HD036071, HD36071, R01 HD036071-10] Funding Source: Medline
  4. NINDS NIH HHS [NS044299, R01 NS044299] Funding Source: Medline

Ask authors/readers for more resources

Background: Multiple sclerosis (MS) and fragile X-associated tremor/ataxia syndrome (FXTAS) have overlapping clinical signs and symptoms. Objectives: To present a case with evidence of both MS and FXTAS and to discuss the relationship of both disorders. Design: Case report. Setting: Fragile X Research and Treatment Center at the University of California, Davis, Medical Center. Patient: Woman with the FMR1 premutation who died of MS at the age of 52 years. Main Outcome Measures: Magnetic resonance imaging, physical examination, and neuropathologic examination results. Results: Magnetic resonance imaging, physical examination, and autopsy neuropathologic examination revealed diagnostic features of MS and FXTAS. Conclusion: The molecular mechanism of RNA toxicity, including the elevation of alpha B-crystallin levels observed in FXTAS, may lead to enhanced predisposition to autoimmune diseases.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.0
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available